HomeInsightsStock Comparison

Natco Pharma Ltd vs Zydus Lifesciences Ltd Stock Comparison

Natco Pharma Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: Apr 27, 2025

Key Highlights

  • The Latest Trading Price of Natco Pharma Ltd is ₹ 889.65 as of 25 Apr 15:30.
  • The P/E Ratio of Natco Pharma Ltd changed from 20 on March 2020 to 12.3 on March 2024 . This represents a CAGR of -9.26% over 5 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 23.3 on March 2020 to 26.2 on March 2024 . This represents a CAGR of 2.37% over 5 years.
  • The Market Cap of Natco Pharma Ltd changed from ₹ 9215 crore on March 2020 to ₹ 17042 crore on March 2024 . This represents a CAGR of 13.08% over 5 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 27344 crore on March 2020 to ₹ 101151 crore on March 2024 . This represents a CAGR of 29.90% over 5 years.
  • The revenue of Natco Pharma Ltd for the Dec '24 is ₹ 651.1 crore as compare to the Sep '24 revenue of ₹ 1434 crore. This represent the decline of -54.62% The revenue of Zydus Lifesciences Ltd for the Dec '24 is ₹ 5326 crore as compare to the Sep '24 revenue of ₹ 5305 crore. This represent the growth of 0.4%.
  • The ebitda of Natco Pharma Ltd for the Dec '24 is ₹ 215.1 crore as compare to the Sep '24 ebitda of ₹ 868.1 crore. This represent the decline of -75.22% The ebitda of Zydus Lifesciences Ltd for the Dec '24 is ₹ 1444 crore as compare to the Sep '24 ebitda of ₹ 1529 crore. This represent the decline of -5.56%.
  • The net profit of Natco Pharma Ltd changed from ₹ 420.3 crore to ₹ 132.4 crore over 7 quarters. This represents a CAGR of -48.32% The net profit of Zydus Lifesciences Ltd changed from ₹ 1112 crore to ₹ 1004 crore over 7 quarters. This represents a CAGR of -5.66% .
  • The Dividend Payout of Natco Pharma Ltd changed from 25.89 % on March 2020 to 13.01 % on March 2024 . This represents a CAGR of -12.86% over 5 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 8.77 % on March 2024 . This represents a CAGR of -19.14% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Natco Pharma Ltd

  • Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs).
  • The Company's focus is primarily on niche therapeutic areas and complex products.
  • It sells products in over 40 countries.
  • FDF products are sold in the United States, India, Europe and the rest of the world (RoW).
  • Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides. Natco Pharma is also engaged in contract manufacturing business, whereby the company undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Natco Pharma Ltd News Hub

News

Natco Pharma update on launch of Risdiplam in India

Natco Pharma today updates on the legal proceedings on Risdiplam launch in India. The Comp...

Read more

08 Apr 2025 11:16

News

Natco Pharma Ltd up for fifth session

Natco Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 8...

Read more

07 Mar 2025 13:00

News

Natco Pharma Ltd soars 1.69%

Natco Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 837...

Read more

25 Feb 2025 13:05

News

Natco Pharma slips as Q3 PAT slides 38% YoY to Rs 132 cr

Profit before tax in Q3 FY25 stood at Rs 163.7 crore, down 36.13% as against Rs 256.3 cror...

Read more

13 Feb 2025 11:11

News

Natco Pharma Ltd drops for fifth straight session

Natco Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 997, ...

Read more

13 Feb 2025 13:35

News

Natco Pharma Ltd leads losers in 'A' group

Orchid Pharma Ltd, Vijaya Diagnostic Centre Ltd, FDC Ltd and Aegis Logistics Ltd are among...

Read more

13 Feb 2025 15:00

Zydus Lifesciences Ltd News Hub

News

Zydus Life gets 6 observations from USFDA for API plant

The inspection, which ran from 21 to 25 April 2025, culminated with six observations issue...

Read more

26 Apr 2025 11:02

News

Zydus's API unit at Dabhasa, Gujarat concludes USFDA inspection

Zydus Lifesciences announced that the USFDA conducted a surveillance inspection at the gro...

Read more

26 Apr 2025 11:57

News

Zydus Lifesciences to hike its stake in Amplitude Surgical SA

Zydus Lifesciences has signed the share purchase agreement to acquire 75.4% of the share c...

Read more

26 Apr 2025 12:24

News

Zydus Lifesciences Ltd leads losers in 'A' group

Easy Trip Planners Ltd, Dhani Services Ltd, Mahanagar Gas Ltd and Astrazeneca Pharma India...

Read more

16 Apr 2025 15:00

News

Zydus Life gets USFDA nod for Deflazacort tablets to treat Duchenne muscular dystrophy

The product is the generic equivalent of Emflaza tablets, and is indicated for the treatme...

Read more

12 Apr 2025 10:22

News

Zydus receives USFDA approval for Jaythari' (Deflazacort) Tablets

Zydus Lifesciences  has received final approval from the United States Food and Drug Admin...

Read more

12 Apr 2025 13:35

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Natco Pharma Ltd

Strength

4

S

Weakness

3

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Natco Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Natco Pharma Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Natco Pharma Ltd or Zydus Lifesciences Ltd?

Market cap of Natco Pharma Ltd is 15,934 Cr while Market cap of Zydus Lifesciences Ltd is 86,445 Cr

What are the key factors driving the stock performance of Natco Pharma Ltd and Zydus Lifesciences Ltd?

The stock performance of Natco Pharma Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Natco Pharma Ltd and Zydus Lifesciences Ltd?

As of April 27, 2025, the Natco Pharma Ltd stock price is INR ₹889.65. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹859.1.

How do dividend payouts of Natco Pharma Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Natco Pharma Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions